View real examples of searches completed by our scientific recruiters

Our scientific recruiters have a proven track record of finding top-tier candidates for a wide range of scientific jobs in the life sciences industry. Below are a few examples of searches we have completed over the last few years.

Research & Discovery

Permanent

  • Vice President, CNS Gene Editing, Cambridge, MA, Mid-size biotech developing CNS therapeutics
  • Director of Bioinformatics and Head of Data Science, Cambridge, MA, Small biotech company developing RNA based gene therapies for complex diseases
  • Director of In Vitro Pharmacology, Boston, MA, Midsized biotech company developing artificial intelligence powered drug discovery
  • Director, Biology, Cambridge, MA, Small clinical supply chain focused in production and distribution of product to trial sites
  • Director, RNA & Protein Sciences, Boston, MA, Startup biotech company developing RNA-Directed Therapeutics for Oncology and Immunology
  • Director, Preclinical Safety, Cambridge, MA, Midsized biotech developing RNA Therapeutics for multiple therapeutic areas
  • Associate Director, Oncology, Boston, MA, Startup biotech company developing RNA-Directed Therapeutics for Oncology and Immunology
  • Associate Director, Immuno-Oncology, Boston, MA, Large pharma company using R&D for multiple therapeutic areas
  • Associate Director, Protein Engineering, Cambridge, MA, Mid-size biotech developing CNS therapeutics
  • AD, Immunology (Macrophage Cell Therapy), Cambridge, MA, Small pharma creating new generation of cellular medicine
  • Senior Computational Biologist, Boston, MA, Small biotech company developing RNA for multiple therapeutic areas
  • Principal Scientist, Structural Biology, Cambridge, MA, Mid-size biotech developing therapeutics related to the Central Nervous System
  • Principal Scientist, Protein Biochemistry, Cambridge, MA, Mid-size biotech using iPSC technology
  • Principal Scientist, Gene Editing, Boston, MA, Small biotech company working with stem cell based cellular therapies
  • Principal Scientist, Biochemistry, Boston, MA, Startup biotech company developing RNA-Directed Therapeutics for Oncology and Immunology
  • Principal Scientist, Target Identification and Validation group, Boston, MA, Startup biotech company developing RNA-Directed Therapeutics
  • Principal Scientist, Mass Spectrometry, Cambridge, MA, Midsized pharma developing biologics, cell & gene therapy
  • Principal Scientist, Cambridge, MA, Small biotech company developing cell and gene therapy for multiple areas
  • Associate Principal Scientist, Bedford, MA, Midsized biotech using protein expression with RNA-based medicines
  • Senior Scientist, RNA Molecular Biology, Waltham, MA, Large tech driven company developing cell, viral, and regenerative medicine therapeutics
  • Senior Scientist, Immunology, Waltham, MA, Large biotech company developing cell and gene therapy for various therapeutic areas
  • Senior Scientist, Pluripotent Stem Cells, Greater Boston, MA, Small biotech company working with stem cell based cellular therapies
  • Sr Associate Scientist, Analytical Development, Boston, MA, Small biotech company using viral engineering vector gene and cell therapy
  • Senior Scientist, Comp Bio, Cambridge, MA, Small biotech company developing cell and gene therapy for multiple areas
  • Senior Scientist, Analytical Development, Boston, MA, Midsized biotech specializing in cell & gene therapy
  • Senior Scientist, Comp Biology, Cambridge, MA, Small biotech developing gene editing for metabolic diseases and oncology
  • Senior Scientist II, Protein Sciences, Watertown, MA, Stealth biotech company for novel targets and ground-breaking therapeutics for various indications
  • Senior Scientist, Ex Vivo, Cambridge, MA, Small biotech company developing cell and gene therapy for multiple areas
  • Scientist II, Cambridge, MA, Medium sized pharma developing allo-engineering within immunology
  • Scientist I, Gene Editing, Lexington, MA, Stealth biotech developing gene editing for genetic therapeutics approach
  • Scientist I, Molecular/Viral Vector Biology, Waltham, MA, Large biotech developing cell and gene therapy for various therapeutic areas
  • Scientist, Natick, MA, Small biotech company working with stem cell based cellular therapies
  • Scientist, tRNA Biology, Boston, MA, Small biotech developing tRNA based therapeutics
  • Scientist, Bioanalytical, Cambridge, MA, Midsized biotech developing Antibody-Drug conjugates for Oncology
  • Scientist, Bioinformatics, Cambridge, MA, Midsized biotech using circular RNA for multiple disease areas
  • Scientist, Mass Spectrometry, Burlington, MA, World leading CRO partner developing cell & gene therapies
  • Cell Culture Scientist, Cambridge, MA, Small biotech working on biologics, cell & gene therapy
  • NGS Scientist, Burlington, MA, World leading CRO partner developing cell & gene therapies
  • Scientist Viral Vector Engineering and Production, Cambridge, MA, Small biotech company developing cell and gene therapy for multiple areas
  • Scientist II, Bioanalytical Assay Development, Cambridge, MA, Midsized biotech company using gene therapy for heart disease
  • Scientist II, Immuno-Oncology, Cambridge, MA, Clinical stage biotech company working with T cells
  • Scientist I, Immunology, Watertown, MA, Stealth company using next generation targeted delivery of biologics
  • Scientist, Burlington, MA, World leading CRO partner developing cell & gene therapies
  • Scientist I, DNA Assembly, Cambridge, MA, Small biotech company developing cell and gene therapy
  • Associate Scientist, Physical Chemistry, Greater Boston, MA, Medium sized biotech cell & gene therapies
  • Associate Scientist II, Lentiviral Vectors, Waltham, MA, Large biotech developing cell, viral, and regenerative medicine therapeutics
  • Associate Scientist Immunotherapy, Waltham, MA, Large biotech developing cell, viral, and regenerative medicine therapeutics
  • Associate Scientist, Oligonucleotide Chemistry, Watertown, MA, Stealth company using next generation targeted delivery of biologics
  • Associate Scientist, In Vitro Pharmacology, Bedford, MA, Midsized biotech company using ASOs to restore protein levels
  • Associate Cell Culture Scientist, Burlington, MA, World leading CRO partner developing cell & gene therapies

Contract

  • Computational Biologist, Data Sciences, Cambridge, MA, large biotech company working with cellular metabolism in rare diseases
  • Contractor, Biologist, Hematology, Cambridge, MA, large biotech company working with cellular metabolism in blood disorders
  • In Vivo Resources Associate, Pharmacology, Cambridge, MA, large biotech company working with cellular metabolism in blood disorders and rare diseases
  • Associate Scientist, NGS, Boston, MA, Rapidly growing startup developing unique molecular approach for Gene Therapy
  • Associate Scientist/Sr. Associate Scientist, Boston, MA, Rapidly growing startup using gene therapy for discovery and development
  • Principal Associate Scientist, Boston, MA, Rapidly growing startup developing molecules for Gene Therapy
  • Sr Clinical Scientist II (Associate Director), Cambridge, MA, Large biopharma company developing novel therapeutics in Epigenetics
  • Associate Scientist, Vector Production, Boston, MA, Midsized preclinical stage company developing next gen viral vector therapy for countless diseases
  • Associate Scientist II, Biology, Boston, MA, Midsized preclinical stage company using next gen viral vector therapy for countless diseases
  • Associate Scientist I, Immuno-Oncology, Boston, MA, Midsized company using next gen viral vector therapy for countless diseases
  • Chemistry Production Tech, Cambridge, MA, Small biotech developing peptide synthesis for Oncology
  • Senior Research Associate, Cell Biologist, Pre-Clinical NGS, Cambridge, MA, Large biotech using CRISPR for Various Cancers and Autoimmune Diseases
  • Research Associate, Analytical Development – Bioassay, Cambridge, MA, Large biotech developing gene therapy for genetic diseases
  • Research Associate Molecular Design and Delivery, Boston, MA, Small bio-innovation company using novel non-viral gene therapy
  • RA I/II, Molecular Assay Development/Analytical Development, Boston, MA, Small bio-innovation company developing novel non-viral gene therapy to treat broad range of diseases
  • Senior Research Associate, Boston, MA, Small biotech platform for protein based therapeutics in animal health
  • Research Associate, Boston, MA, Small startup biotech platform for protein based therapeutics in animal health
  • Scientific Consultant – Preclinical Team, Waltham, MA, Midsize biotech developing antibodies to protect from serious viral diseases
  • RA, Bioanalytical, Boston, MA, Midsized biotech developing synthetic biology and beneficial microbes to solve agricultural challenges
  • Research Associate/ Senior Research Associate, Cambridge, MA, Stealth mode startup developing oligonucleotide based therapies
  • Research Associate I,Lexington, MA, Clinical stage biopharma focused on novel treatments for hematological and musculoskeletal disorders
  • Research Associate II, Lexington, MA, Midsized clinical stage biopharma focused on novel treatments for hematological and musculoskeletal disorders
  • Research Associate I/II, In Vivo, Lexington, MA, Clinical stage biopharma focused on novel treatments for hematological and musculoskeletal disorders
  • Research Associate, Oligonucleotide Chemistry, Cambridge, MA, Midsized biotech developing RNA editing for genetic diseases
  • (Sr.) Research Associate/Associate Scientist, Cell Biology, Cambridge, MA, Midsized biotech developing RNA editing for genetic diseases
  • RA I, HTS, Cambridge, MA, Midsized biotech developing RNA editing for genetic diseases
  • RA, Cell Biology, Cambridge, MA, Midsized biotech developing RNA editing for genetic diseases
  • Research Associate, High-throughput Screening, Cambridge, MA, Midsized biotech developing RNA editing for genetic diseases
  • RA, Platform Discovery, Cambridge, MA, Midsized biotech developing RNA editing for genetic diseases
  • Associate Scientist, Oligonucleotide Manufacturing,Cambridge, MA, Midsized biotech developing RNA editing for genetic diseases
  • Research Associate, High-throughput Screening, Cambridge, MA, Midsized biotech developing RNA editing for genetic diseases
  • Research Associate, Oligonucleotide Compound Management, Cambridge, MA, Midsized biotech developing RNA editing for genetic diseases
  • Research Associate, Oligonucleotide Chemistry, Cambridge, MA, Midsized biotech developing RNA editing for genetic diseases
  • RA I/II, In Vivo Pharmacology, Cambridge, MA, Midsized biotech developing RNA editing for genetic diseases
  • RA I/II, HTS, Cambridge, MA, Midsized biotech developing precision medicine for rare genetic diseases
  • Senior Scientist II, Boston, MA, Commercial stage biopharma company developing antibody and protein technology redefining how cancer is treated
  • RA I- Molecular Technologies, Cambridge/Waltham, MA, Microbiome therapeutics platform company developing novel class
  • Operations Associate II/Sr. Associate          , Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • Associate I, Analytical Operations, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • Associate Scientist, Discovery Biology, Watertown, MA, Stealth company using next generation targeted delivery of biologics possible metabolic, muscle, neuro and immunological indications
  • Senior Research Associate, Cell and Molecular Biology, Cambridge, MA, Small biotech company developing cell and gene therapy for multiple areas
  • RA, Pharmacology, Cambridge, MA, Small biotech company developing cell and gene therapy for multiple areas
  • Sr RA Human Therapeutics, Cambridge, MA, Small biotech company developing cell and gene therapy for multiple areas
  • Sr Research Associate, Platform Engineering, Cambridge, MA, Small biotech company developing cell and gene therapy for multiple areas
  • Sr Research Associate, Cambridge, MA, Small biotech company developing cell and gene therapy for multiple areas
  • Sr Research Associate, Virus Production, Cambridge, MA, Small biotech company developing cell and gene therapy for multiple areas
  • Research Associate, Discovery, Cambridge, MA, Small biotech company developing cell and gene therapy for multiple areas
  • Research Associate, Chemistry, Cambridge, MA, Small biotech company developing cell and gene therapy for multiple areas
  • Research Associate, Molecular Biology, Cambridge, MA, Small biotech company developing cell and gene therapy for multiple areas
  • Senior Research Associate, Molecular Biology, Cambridge, MA, Small biotech company developing cell and gene therapy for multiple areas

Clinical & Regulatory

Permanent

  • SVP Clinical Operations – Neuro, Needham, MA: Small-Mid sized biotech committed to providing a brighter future for patients suffering from neurological disorders
  • Chief Medical Officer, Waltham, MA: Small, clinical-stage biopharma focused in immune-oncology 
  • Vice President, Clinical Development – Rare Disease, Boston, MA:  Small growing clinical-stage biotech developing small molecule therapeutics to treat diseases caused by dysfunctional protein processing
  • Vice President, Clinical Operations -Oncology, Watertown, MA: Small immuno-oncology company advancing a pipeline of next generation, transformative cancer treatments
  • Chief Medical Officer – Rare Disease, Charlestown, MA: Small biotech focused on discovering small molecules that help restore CFTR protein
  • VP Clinical Development – Oncology, Cambridge, MA:  Mid-Sized biotech focused in precision therapy to create life-changing medicines for cancer and blood disorders
  • Chief Medical Officer – Neuro, Waltham, MA: Small, drug discovery and development company focused on revolutionizing disease treatment with small molecules
  • VP Clinical Development Operations, Cambridge, MA:  Small, early-stage Boston-area startup company working at the frontier of immuno-oncology
  • Senior Medical Director – CNS, Boston, MA: Mid-Sized biotech focused in RNA-targeted therapy
  • VP Clinical Development, Waltham, MA: Small, clinical-stage biopharma focused in immune-oncology
  • VP Biometrics, Boston, MA:  Small, late-stage biopharmaceutical company focused on the discovery, development and commercialization of small molecule therapeutics
  • VP Biometrics – Oncology, Waltham, MA:  Small, clinical- stage biopharmaceutical company developing an innovative pipeline of cancer therapies
  • VP Clinical Operations – Cell Therapy, Cambridge, MA:  Small biotech pioneering a platform technology for donor-independent blood stem cell transplants
  • VP Clinical Development – Cardio, Boston, MA:  Small, late-stage biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule therapeutics
  • VP Clinical Development – Oncology, Cambridge, MA:  Mid-Sized biotech focused in precision therapy to create life-changing medicines for cancer and blood disorders
  • VP Clinical Operations – Cell Therapy, Waltham, MA: Mid-Sized Biotech leading the development of innovative cell therapies, focused on restoring natural immunity in patients with severely compromised immune systems
  • VP Clinical Development Operations, Cambridge, MA:  Small, early-stage Boston-area startup company working at the frontier of immuno-oncology
  • VP Clinical Development ,Waltham, MA: Small, clinical-stage biopharma company focused in immune-oncology
  • VP Program Management – Cell Therapy, Boston, MA:  Small biotech advancing a pipeline of first-in-class medicines to address significant unmet medical needs in orphan pulmonary and fibrosis diseases
  • VP Clinical Development, Waltham, MA: Small, clinical-stage biopharma focused in immune-oncology
  • VP Clinical Operations, Boston, MA:  Small, late-stage biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule therapeutics
  • VP Program Management – Cell Therapy, Cambridge, MA:  Small biotech pioneering a platform technology for donor-independent blood stem cell transplants
  • VP Clinical Operations – CNS/Derm, Wellesley MA: Small biotech focused on developing treatments for dermatology products
  • VP Clinical Operations – Immuno-oncology, Waltham, MA: Small, clinical-stage biopharma focused in immune-oncology
  • VP Clinical Operations – Neuro, Waltham, MA:  Small drug discovery and development company focused on revolutionizing disease treatment with small molecules
  • VP Clinical Operations, Rare Disease, Boston, MA:  Small, growing, clinical-stage biotech company developing small molecule therapeutics to treat diseases caused by dysfunctional protein processing
  • VP Regulatory Affairs, Boston, MA: Small-Mid sized biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare pathway diseases
  • VP Regulatory and Quality – Rare Disease, Lexington, MA:  Medium-sized, clinical-stage biopharmaceutical company focused on the creating treatments for patients suffering from rare disorders
  • Chief Medical Officer – Rare Disease, Boston, MA: Small, clinical-stage biopharmaceutical company developing small molecule therapeutics to treat diseases caused by dysfunctional protein processing
  • Senior Medical Director – Neuro, Woburn, MA: Small, late-clinical stage biopharmaceutical company focused on creating therapies for patients suffering from serious gastrointestinal (GI) diseases
  • Senior Medical Director – Neurology, Needham, MA: Small-Mid Sized biotech committed to providing a brighter future for patients suffering from neurological disorders
  • Medical Director – Hematology, Lexington, MA:  Medium sized, clinical-stage biopharmaceutical company focused on the creating treatments for patients suffering from rare disorders
  • Medical Director, Microbiome, Boston, MA:  Small, clinical-stage biopharmaceutical company focused on harnessing the power of the human gut microbiome
  • Medical Director, Rare Disease, Boston, MA:  Small-Mid sized biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare pathway diseases
  • Sr. Director Clinical Operations – Multiple Therapeutics, Cambridge, MA:  Large, clinical stage genome editing company working with CRISPR systems to develop treatments for serious diseases
  • Sr. Director Medical Communications – Rare Disease, Boston, MA:  Small-Mid sized biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare pathway diseases
  • Sr. Director, Biostatistics, Boston, MA:  Small-Mid sized biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare pathway diseases
  • Sr. Director, Clinical Operations, Cambridge, MA:  Small, clinical-stage development company with a portfolio focused on immune modulatory drugs for neurodegenerative disease
  • Sr. Director, Clinical Operations, Cambridge, MA:  Small Biotech with a strong foundation in immuno-oncology and translational cancer medicine, focused in molecules and biologics
  • Sr. Director, Clinical Operations, Boston, MA: Small biopharmaceutical company developing innovative treatments for resistant bacterial infections
  • Sr. Director, Clinical Operations – Gene Therapy, Cambridge, MA: Small, clinical-stage biotechnology company focused in retinal gene therapy
  • Sr. Director, Clinical Operations – Orphan Disease, Needham, MA: Small-Mid Sized biotech committed to providing a brighter future for patients suffering from neurological disorders
  • Sr. Director, Clinical Scientist – Oncology, Cambridge, MA: Large, clinical-stage genome editing company working with CRISPR systems to develop treatments for serious diseases
  • Sr. Director, Regulatory Affairs – Rare Disease, Cambridge, MA:  Small biopharmaceutical company specializing in developing drugs for the treatment of cancer
  • Sr. Director, Regulatory Affairs – Rare Disease, Boston, MA:  Small biotechnology company working on a treatment for patients with a specific genetic brain disorder
  • Senior Director, Regulatory Affairs – Rare Disease, Boston, MA:  Small-Mid sized biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare pathway diseases
  • Senior Director, Field Based, Cambridge, MA: Medium sized biopharma company developing antibody and protein technology for oncology and autoimmune diseases
  • Executive Director, Trial Management – Neuroscience, Lexington, MA:  Medium-sized, clinical-stage biopharmaceutical company focused in creating treatments for patients suffering from rare disorders
  • Director Clinical Operations, Watertown, MA:  Mid Sized biotech dedicated to developing transformative medicines to restore the minds of people with serious brain disease
  • Director Clinical Operations, Cambridge, MA:  Small, clinical-stage biotech company leveraging stem cell biology and biotherapeutics to expand the accessibility of stem cell transplantation
  • Director Clinical Operations – Oncology, Cambridge, MA:  Large, innovative pharmaceutical company committed to developing future medicines for patients in therapeutic areas such as oncology, central nervous system, autoimmunity, and anti-infection
  • Director Data Management, Watertown, MA: Mid-Sized biopharma company pioneering innovative chemistry to discover and develop unique therapeutics to treat various disease
  • Director Data Management – Oncology, Cambridge, MA:  Small, clinical-stage biopharmaceutical company developing  therapeutics for cancer research.
  • Director Medical Affairs – Neuro, Needham, MA: Small-Mid Sized biotech committed to providing a brighter future for patients suffering from neurological disorders
  • Director – Medical Writing, Lexington, MA:  Medium sized, clinical-stage biopharmaceutical company focused in creating treatments for patients suffering from rare disorders
  • Director, Clinical Operations – I/O, Waltham, MA: Small, clinical-stage biopharma focused in immune-oncology
  • Director, Clinical Operations – Oncology, Watertown, MA:  Mid-Sized biopharmaceutical company dedicated to first-in-class therapeutic candidates transforming the lives of patients with hematologic disorders
  • Director, Clinical Operations – Oncology, Woburn, MA: Small biotech dedicated to discovering and developing novel medicines that effectively address diseases emerging from respiratory distress.
  • Director, Clinical Outsourcing, Cambridge, MA: Small, clinical-stage biotechnology company focused in retinal gene therapy
  • Director, Clinical Pharmacology, Boston, MA:  Small, late-stage biopharmaceutical company focused on the discovery, development and commercialization of small molecule therapeutics
  • Director, Medical Writing, Cambridge, MA:  Mid-Sized biotech focused in innovative gene editing to discover and develop curative treatments for genetic diseases
  • Director, Patient Enrollment – Gene Therapy, Cambridge, MA:  Small, clinical-stage biotechnology company focused in retinal gene therapy
  • Director, Program Management – Oncology, Watertown, MA: Small immuno-oncology company advancing a pipeline of next generation, transformative cancer treatments
  • Director, Regulatory Affairs, Lexington, MA: Large global biopharma with a focus on people living with infertility, multiple sclerosis and cancer
  • Director, Regulatory Affairs, Arlington, MA:  Small, clinical-stage biopharmaceutical company focused on developing therapies for severe and rare eye diseases
  • Director, Regulatory Affairs, Boston, MA:  Small biotechnology company working on a treatment for patients with a specific genetic brain disorder
  • Director, Regulatory CMC, Cambridge, MA: Large, clinical- stage genome editing company working with CRISPR systems to develop treatments for serious diseases
  • Director, Regulatory Operations – I/O, Waltham, MA: Small, clinical-stage biopharma focused in immune-oncology
  • Director/AD Clinical Business Operations, Thousand Oaks, CA:  Small biotech pioneering a platform technology for donor-independent blood stem cell transplants
  • Director, Medical Writing, Boston, MA:  Small, late-stage biopharmaceutical company focused on the discovery, development and commercialization of small molecule therapeutics
  • Head of Biostats, Boston, MA: Small biotechnology company developing new drugs targeting brain metabolism
  • Head of Clinical Operations, Cambridge, MA: Small biotech that acquires and transforms innovative molecules into life-improving medicines across multiple therapeutic areas
  • Head of Clinical Operations, Boston, MA: Large global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases
  • Head of Regulatory Affairs – Oncology/Rare Disease, Burlington, MA: Publicly traded biopharmaceutical company focused on the discovery and development of therapies for cancer and other rare diseases
  • Head of Regulatory Affairs – Rare Disease, Cambridge, MA: Biotechnology company translating cutting edge technology for innovative treatments for patients with rare disorders
  • Senior Manager, PV, Boston, MA: Small-Mid sized biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare pathway diseases
  • AD Clinical Project Management – Hematology, Lexington, MA:  Medium sized, clinical-stage biopharmaceutical company focused on treatments for patients suffering from rare disorders
  • AD Clinical Scientist – Hem/Onc/Immunology, Waltham, MA:  Large biotech focused on developing antibody-drug conjugates
  • Associate Director, Clinical Operations, Cambridge, MA:  Large Biotech leading the way in groundbreaking research to develop health solutions for diseases in both humans and animals
  • Associate Director, Clinical Operations – Cell Therapy, Waltham, MA:  Mid Sized Biotech leading the development of innovative cell therapies, focused on restoring natural immunity in patients with severely compromised immune systems
  • Associate Director, Clinical Operations – Immunotherapy, Palo Alto, CA:  Small biotech focused in immunotherapy to develop and deliver transformative medicines for patients with cardiovascular disease
  • Associate Director, Clinical Operations – Rare Disease, Charlestown, MA: Small biotech focused on discovering small molecules that help restore CFTR protein
  • Associate Director, Clinical Operations – Rare Disease, Cambridge, MA:  Mid-Sized biotech company specializing in the discovery and development therapeutics for rare immune-mediated diseases
  • Associate Director, Medical Affairs, Boston, MA:  Small biopharmaceutical company, focused on discovering, developing, and commercializing small molecule drugs
  • Associate Director, Program Management, Waltham, MA: Mid-Sized Biotech leading in the development of innovative cell therapies, focused on restoring natural immunity in patients with severely compromised immune systems
  • Sr. Manager, Clinical Operations, Needham, MA:  Small development-stage biopharmaceutical company dedicated to creating and bringing to market medicines for cancer
  • Sr. Manager, Clinical Outsourcing, Waltham, MA:  Large biopharmaceutical company using proprietary kinase inhibitors and extensive knowledge in kinase biology to develop and commercialize innovative cancer medicine
  • Sr. Manager, Medical Writing, Cambridge, MA:  Large, clinical-stage genome editing company working with CRISPR systems to develop treatments for serious diseases
  • Sr. Manager, Medical Writing, Needham, MA: Small-Mid sized biotech committed to providing a brighter future for patients suffering from neurological disorders
  • Manager, Data Management, Waltham, MA:  Large biopharmaceutical company using proprietary kinase inhibitors and extensive knowledge in kinase biology to develop and commercialize innovative cancer medicine
  • Manager, TMF, Cambridge, MA: Small, clinical-stage biotechnology company focused in retinal gene therapy
  • Manager, Trail Master File- CNS, Boston, MA: Small, clinical-stage biopharmaceutical company focused on patients with diabetic neuropathy and Alzheimer’s disease
  • Principal Clinical Data Manager, Watertown, MA: Mid-Sized biopharma company pioneering innovative chemistry to discover and develop unique therapeutics to treat various disease
  • Principal Clinical Trial Lead, Lexington, MA: Large, global biopharma focused on people living with infertility, multiple sclerosis and cancer
  • Principal, Clinical Data Management, Watertown, MA: Mid-Sized biopharma company pioneering innovative chemistry to discover and develop unique therapeutics to treat various disease
  • Senior Clinical Data Manager, Waltham, MA: Small, clinical-stage biopharma focused in immune-oncology
  • Senior Clinical Data Manager, Needham, MA:  Small, development-stage biopharmaceutical company dedicated to creating and bringing to market medicines for cancer
  • Senior Clinical Trial Manager, Waltham, MA: Large, oncology-focused biotech discovering candidates that modulate the function of the immune system
  • Senior CTM, Watertown, MA: Mid-Sized biopharma company pioneering innovative chemistry to discover and develop unique therapeutics to treat various disease
  • Clinical Operations Lead, Boston, MA:  Small, late-stage biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule therapeutics
  • Clinical Operations Lead, Cambridge, MA:  Small biotech that acquires and transforms innovative molecules into life-improving medicines across multiple therapeutic areas
  • Clinical Project Manager, Watertown, MA: Mid-Sized biopharma company pioneering innovative chemistry to discover and develop unique therapeutics to treat various disease
  • Clinical Scientist – Hematology/Oncology, Waltham, MA:  Small, clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies
  • Clinical Trial Lead, Waltham, MA: Large, oncology-focused biotech discovering candidates that modulate the function of the immune system
  • Clinical Trial Manager, Boston, MA: Small biotech focused on translating innovative science to develop and deliver innovative therapies for cancer
  • Clinical Trial Manager – Oncology/I-O, Waltham, MA: Small, clinical-stage biopharma focused in immune-oncology
  • Medical Science Liaison, Boston, MA: Midsized company developing gene therapy for countless diseases
  • Site Relationship and Operations Lead, Lexington, MA: Large, global biopharma that is focused on people living with infertility, multiple sclerosis and cancer
  • Sr. Clinical Project Manager, Boston, MA: Small, global biotech focusing on oral small molecule therapies for fibrosis, lysosomal storage disorders, and oncology
  • Sr. Clinical Project Manager – CNS, Diabetes, Pain, Boston, MA: Small, clinical-stage biopharmaceutical company focused on unmet needs in patients with diabetic neuropathy and Alzheimer’s disease
  • Sr. Clinical Trial Manager – Oncology Waltham, MA: Small, clinical-stage biopharma focused in immune-oncology

Contract

  • Manager of Clinical Data Management, Cambridge, MA, large biotech company working with cellular metabolism in rare diseases
  • Manager/Lead, Clinical Data Management, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • Clinical Trial Associate, Los Angeles, CA, Biotech development novel medicines targeting metabolic and age-related diseases
  • Clinical Trial Manager, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • Senior Clinical Trial Manager, Cambridge, MA, Midsized biotech developing Antibody-Drug conjugates for Oncology
  • Clinical Operations Manager, Cambridge, MA, Large biopharma company developing novel therapeutics in Epigentics
  • Clinical Sample Associate, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • Trial Monitoring Manager, Cambridge, MA, Large biopharma company developing antibody and protein technology for Oncology
  • Pharmacovigilance Contractor, Waltham, MA, Large biotech developing Antibody-Drug Conjugates for Oncology
  • Sr Trial Master File Specialist, Cambridge, MA, Midsized biotech developing Antibody-Drug conjugates for Oncology
  • Trial Monitoring Manager, Boston, MA, Commercial stage biopharma company developing antibody and protein technology for oncology and autoimmune diseases
  • Clinical Sample Associate I, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • Senior Manager CDM/Lead CDM, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • Clinical Trial Manager, Auburndale, MA, Midsized innovative biotech bringing mitochondrial targeted therapies to treat common and rare diseases
  • Technical Writer, Waltham, MA, Large biotech developing Antibody-Drug Conjugates for anticancer therapeutics
  • Clinical Sample Associate – Biotech, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • Sr Manager Medical Writing, Boston, MA, Large biopharma company developing antibody and protein technology for oncology and autoimmune diseases
  • Senior Clinical Trial Associate, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases

Technical Operations/CMC/Quality

Permanent

  • Director, CMC Analytical Development, Cambridge, MA, Mid-size biotech developing CNS therapeutics using iPSC technology
  • Laboratory Operations Manager, Cambridge, MA, Small biotech developing transformative platform to manufacture cell-based therapies
  • AD, Analytical Chemistry, Littleton, MA, Small biotech company progressing psychedelic therapeutics for psychiatric disorders
  • Sr Director of Gene Therapy & Process Development, Cambridge, MA, Large biotech focused on genome editing for people living with serious diseases
  • Principal Scientist, Cell Therapy Process Development, Waltham, MA, Large biotech developing cell, viral, and regenerative medicine therapeutics for the treatment of severe diseases
  • Vector Production Lead, Boston, MA, Preclinical stage company using next gen viral vector therapy for countless diseases
  • Sr Manager, Vector Production, Boston, MA, Midsized company developing cell and gene therapy for multiple therapeutics areas
  • Scientist, Associate Director, Downstream Process Development and Conjugation, Cambridge, MA, Small biotech developing antibody-drug conjugates for wide range hard to treat cancers
  • Principal Scientist, Scale Up Process Development, Natick, MA, Small biotech company working with stem cell based cellular therapies
  • Principal Scientist, Analytical Development, Natick, MA, Small biotech company working with stem cell based cellular therapies
  • Vice President, Program Management, Natick, MA, Small biotech company working with stem cell based cellular therapies
  • Research Associate, Drug Development, Boston, MA, Small biotech company developing RNA and multiple therapeutics areas
  • Sr Manager Quality Product Testing, Waltham, MA, Large biotech developing Antibody-Drug Conjugates for Oncology
  • Development Associate II, Waltham, MA, Large biotech developing Antibody-Drug Conjugates for anticancer therapeutics
  • Scientist, Analytical Development, Boston, MA, Small biotech developing viral engineering vector gene and cell therapy
  • Principal Scientist, LNP Formulation, Cambridge, MA, Small biotech developing mRNA for use in Oncology
  • AD, Analytical Development, Cambridge, MA, Small clinical stage biotech developing targeted and immuno-oncology therapeutics
  • AD, Clinical Supply Chain, Cambridge, MA, Midstage biotherapeutics client developing immuno-oncology therapies
  • Sr Director, QA, Cambridge, MA, Small clinical stage biotech developing biologics for oncology
  • Associate Director, QA Documentation & Training, Cambridge, MA, Midsized biotech developing Antibody-Drug conjugates for Oncology
  • Senior Director, ADC Analytical Development, Cambridge, MA, Clinical Stage biopharma company developing Antibody-Drug conjugates for Oncology
  • AD, Drug Linker Analytics, Cambridge, MA, Midsized biotech developing Antibody-Drug conjugates for Oncology
  • Scientist, Drug Substance Process Development, Cambridge, MA, Clinical development stage biotech of mRNA for Oncology
  • Director, Head of RNA Production, Cambridge, MA, Midsized biotech developing RNA Therapeutics for multiple therapeutic areas
  • Director, Manufacturing Science & Technology, Cambridge, MA, Midsized biotech using circular RNA for multiple disease areas including cancer, regenerative medicine, protein replacement, infectious disease and autoimmunity
  • Associate Director, Upstream Process Development, Cambridge, MA, Startup developing oncology focused biotherapeutics client
  • Manager of Quality Systems, Burlington, MA, Midsized CRO partner developing biologics, cell & gene therapy
  • AD, GMP Quality Operations, Bedford, MA, Midsized biotech developing RNA focused therapy for genetic diseases
  • AD, Oligonucleotide Drug Substance Manufacturing, Bedford, MA, Midsized biotech using upregulating protein expression with RNA-based medicines
  • Sr. Process Development Engineer, Cambridge, MA, Clinical stage biotech developing synthetic biology for metabolic disorders, immunology, and oncology
  • Sr. Associate, Quality Assurance, Cambridge, MA, Clinical stage biotech developing immunotherapy co novel t cells for oncology
  • AD, Analytical Product Lead, Cambridge, MA, Clinical Stage biotech developing M T-Cell therapies for oncology
  • Lab Manager, Cambridge, MA, Small biotech company developing cell and gene therapy for multiple areas
  • Director LNP Formulation, Cambridge, MA, Small biotech company developing cell and gene therapy for multiple areas
  • Senior Scientist II, Analytical Development, Cell Therapy, Cambridge, MA, Small biotech company developing cell and gene therapy for multiple areas
  • Sr Scientist, Nanoparticle DNA & RNA Drug Delivery, Cambridge, MA, Small biotech company developing cell and gene therapy for multiple areas
  • Scientist, Nanoparticle DNA & RNA Drug Delivery, Cambridge, MA, Small biotech company developing cell and gene therapy for multiple areas
  • Principal RA, mRNA Process Development, Cambridge, MA, Small biotech company developing cell and gene therapy for multiple areas
  • Scientist, Associate Director, Cell Therapy Process Development, Cambridge, MA, Small biotech company developing cell and gene therapy for multiple areas
  • Principal RA, mRNA Manufacturing, Cambridge, MA, Small biotech company developing cell and gene therapy for multiple areas
  • Sr. Associate Principal Scientist, mRNA and LNP Scale Up and Tech Transfer Lead, Cambridge, MA, Midsized biotech company developing gene therapy for heart disease
  • AD, Analytical Development, Cambridge, MA, Midsized biotech company using gene therapy for heart disease
  • AD, QC Operations, Boston, MA, Clinical stage biotech innovating cell therapy for oncology

Contract

  • Sr. RA, Compound Management, Cambridge, MA, Large biotech company working with cellular metabolism in rare diseases
  • Lab Manager, Process Development, South Boston, MA, Large gene editing company focused on transformative gene-based medicines
  • Contractor, Sample Inventory Management, South Boston, MA, Large gene editing company focused on transformative gene-based medicines
  • Lab Manager, Process Development, South Boston, MA, Large gene editing company focused on transformative gene-based medicines
  • Senior Specialist, Quality Systems and Compliance, Waltham, MA, Large biopharma company focused on kinase biology for Oncology
  • QA Documentation Contractor, Waltham, MA, Large biotech developing Antibody-Drug Conjugates for Oncology
  • Lab Assistant, Cambridge, MA, Large biotech using CRISPR for Various Cancers and Autoimmune Diseases
  • Associate Scientist, Production Core, Boston, MA, Small bio-innovation company using novel non-viral gene therapy
  • Lab Operations Associate, Boston, MA, Small bio-innovation company developing novel non-viral gene therapy to treat broad range of diseases
  • RA II, Bioassay Development/Analytical Development, Boston, MA, Small bio-innovation company using novel non-viral gene therapy
  • Scientific Consultant, Technical Operations Team, Waltham, MA, Midsized biotech transcending limits of naturally occurring immunity
  • Associate Scientist, DMPK, Cambridge, MA, Midsized biotech developing RNA editing for genetic diseases
  • RA I/II, In Vivo Pharmacology, Cambridge, MA, Midsized biotech developing precision medicine for rare genetic diseases
  • Lab Operations Associate, Cambridge, MA, Midsized biotech using fungi to produce drugs for intractable human diseases via novel biological mechanisms
  • Quality Assurance Contractor, Cambridge, MA, Clinical Stage biopharma company developing Antibody-Drug conjugates for Oncology
  • CMC Temp, Cambridge, MA, Midsized biotech developing Antibody-Drug conjugates for Oncology
  • R&D Program Management Consultant, Cambridge, MA, Midsized biotech developing Antibody-Drug conjugates for Oncology
  • Principal QA Specialist, Cambridge, MA, Clinical Stage biopharma company developing Antibody-Drug conjugates for Oncology
  • Lab Manager, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • Director of Facilities, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • Project Manager, Quality Control, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • QC Analyst EM, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • GCP Audit Coordinator, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • Lab Support Associate, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • QC Raw Materials Associate I, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • QC Analyst I, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • Manufacturing Associate I, Microbiome, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • CMC Project Manager, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • Warehouse Supply Chain Associate I/II, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • QC Analyst I – Environmental Monitoring, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • Sr. Associate, Procurement, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • QA Specialist II, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • QC Analyst II – Raw Materials, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • Manufacturing Associate, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • QA Specialist II, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • Facilities Associate – Biotech, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • Manufacturing Associate – Microbiome Therapeutics, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • Lab Operations Associate – Biotech, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • QC Analyst I – Environmental Monitoring, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • Facilities Manager, Cambridge/Waltham, MA, Clinical stage company developing microbiome for chronic and inflammatory, infectious disease and oncology
  • External Quality Control Associate, Cambridge, MA, Midsized biotech company developing M T-Cell therapies for oncology
  • Senior Research Associate, Analytical Development Cambridge, MA, Small biotech company developing cell and gene therapy for multiple areas
  • Senior Quality Control Specialist, Boston, MA, Large biotech company creating transformative medicines for serious diseases
  • Materials Management Specialist, Boston, MA, Large biotech company creating transformative medicines for serious diseases

General and Administrative/ Human Resources

  • TA Sourcing Partner, Waltham, MA, Biopharma company discovering novel treatments for Ophthalmology, Nephrology Hematology, and Neurology
  • TA Specialist, Waltham, MA, Biopharma company discovering novel treatments for Ophthalmology, Nephrology Hematology, and Neurology
  • TA Consultant, Waltham, MA, Biopharma company developing complement medicine for rare disease
  • TA Consultant, Waltham, MA, Biopharma company discovering novel treatments for Ophthalmology, Nephrology Hematology, and Neurology
  • Event Coordinator, Waltham, MA, Biopharma company discovering novel treatments for Ophthalmology, Nephrology Hematology, and Neurology
  • Event Planner – Pharma, Waltham, MA, Biopharma company discovering novel treatments for Ophthalmology, Nephrology Hematology, and Neurology
  • Contract Recruiter, Greater Boston, MA, Clinical stage biopharma company developing transformative medicines with small-molecule drugs
  • TA Coordinator, Watertown, MA, Small biotech developing novel therapies for transformative medicines
  • Document Specialist Contractor, South Boston, MA, Large gene editing company focused on transformative gene-based medicines
  • Contract Recruiter, Boston, MA, Midsized preclinical stage company developing next gen viral vector therapy for countless diseases
  • Senior Analyst- Strategic Finance, Boston, MA, Large biotech developing cell programming for multiple applications
  • Talent Acquisition Contractor, Waltham, MA, Large biotech developing Antibody-Drug Conjugates for Oncology
  • Project Administrator, Boston, MA, Small biotech platform for protein-based therapeutics in animal health
  • Contract Recruiter, Cambridge, MA, Clinical Stage biopharma company developing Antibody-Drug conjugates for Oncology
  • Talent Acquisition Contractor, Cambridge, MA, Clinical Stage biopharma company developing Antibody-Drug conjugates for Oncology
  • Accounts Payable Associate, Cambridge, MA, Clinical Stage biopharma company developing Antibody-Drug conjugates for Oncology
  • Manager, Patient Enrollment and Site Engagement, Cambridge, MA, Midsized biotech developing Antibody-Drug conjugates for Oncology
  • Administrative Assistant, Boston, MA, Large biopharma company developing antibody and protein technology for oncology and autoimmune diseases
  • Executive Administrative Assistant to the CSO, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • Temp Executive Administrative Assistant, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • Part-Time Nursing Consultant – Corporate Covid Policy, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • Administrative Assistant – Donor Programs, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • TA Coordinator, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • QC LMS Administrator, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • Audit Coordinator, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • Executive Assistant, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • Compensation and Benefits Consultant, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • Training and Documentation Coordinator, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • Audit Coordinator, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • Inspection Administrative Coordinator, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • AP Specialist, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • Talent Management Consultant, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • Talent Acquisition Coordinator – Biotech, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • IT Service Desk Engineer, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • Office Manager, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • Manager, People and Benefits Operations, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • Quality Assurance Documentation and Training Specialist, Cambridge, MA, Clinical stage biotech developing immunotherapy co novel t cells for oncology
  • Document Control Coordinator, Boston, MA, Clinical stage biotech innovating cell therapy for oncology
  • Talent Operations Specialist, Waltham, MA, Biopharma company discovering novel treatments for Ophthalmology, Nephrology Hematology, and Neurology